title: Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: Implications for use of synovial sublining macrophages as a biomarker.
authors.affiliation: Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
authors.forename: Carla A
authors.initials: CA
authors.lastname: Wijbrandts
authors.forename: Clarissa E
authors.initials: CE
authors.lastname: Vergunst
authors.forename: Jasper J
authors.initials: JJ
authors.lastname: Haringman
authors.forename: Danielle M
authors.initials: DM
authors.lastname: Gerlag
authors.forename: Tom J M
authors.initials: TJ
authors.lastname: Smeets
authors.forename: Paul P
authors.initials: PP
authors.lastname: Tak
mesh_terms: D000906:Antibodies / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000473:pathology* / Q000628:therapy*; D015415:Biomarkers; D001706:Biopsy; D018932:Chemokine CCL2 / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D008264:Macrophages / Q000473:pathology*; D008565:Membrane Proteins / Q000276:immunology; D044087:Receptor, Anaphylatoxin C5a; D011951:Receptors, Complement / Q000276:immunology; D013583:Synovial Membrane / Q000276:immunology / Q000473:pathology*
chemical_list: D000906:Antibodies; D015415:Biomarkers; C488033:C5AR1 protein, human; C111835:CCL2 protein, human; D018932:Chemokine CCL2; D008565:Membrane Proteins; D044087:Receptor, Anaphylatoxin C5a; D011951:Receptors, Complement